Your browser doesn't support javascript.
loading
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
Dominguez-Molina, B; Tarancon-Diez, L; Hua, S; Abad-Molina, C; Rodriguez-Gallego, E; Machmach, K; Vidal, F; Tural, C; Moreno, S; Goñi, J M; Ramírez de Arellano, E; Del Val, M; Gonzalez-Escribano, M F; Del Romero, J; Rodriguez, C; Capa, L; Viciana, P; Alcamí, J; Yu, X G; Walker, B D; Leal, Manuel; Lichterfeld, M; Ruiz-Mateos, E.
Afiliación
  • Dominguez-Molina B; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
  • Tarancon-Diez L; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
  • Hua S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts, USA Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Abad-Molina C; Laboratoy of Immunology, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
  • Rodriguez-Gallego E; Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
  • Machmach K; Department of Medical Microbiology and Immunology, University of California, Davis, Davis, CA, USA.
  • Vidal F; Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
  • Tural C; Fundació Lluita Contra la Sida, Fundacio Irsicaixa, Hospital Universitari Germans Trias i Pujol, Badalona,Spain.
  • Moreno S; Department of Infectious Diseases, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Goñi JM; Department of Endocrinology, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Ramírez de Arellano E; Unidad de Inmunología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
  • Del Val M; Unidad de Inmunología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
  • Gonzalez-Escribano MF; Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain.
  • Del Romero J; Laboratoy of Immunology, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
  • Rodriguez C; Centro Sanitario Sandoval, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Capa L; Centro Sanitario Sandoval, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Viciana P; AIDS Immunopathology Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Alcamí J; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
  • Yu XG; AIDS Immunopathology Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Walker BD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts, USA Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Leal M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts, USA Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lichterfeld M; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
  • Ruiz-Mateos E; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital, Seville, Spain.
Clin Infect Dis ; 64(5): 621-628, 2017 03 01.
Article en En | MEDLINE | ID: mdl-27986689
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígenos HLA-B / Infecciones por VIH / Interleucinas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígenos HLA-B / Infecciones por VIH / Interleucinas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article